Greg J. Zahner, MD, MSc; Peter W. Croughan, MD; Daniel M. Blumenthal, MD, MBA
JAMA. 2022;327(1):29-30. doi:10.1001/jama.2021.23329
This Viewpoint discusses implementation of a 鈥淢edicare Advantage for All鈥 structure as a possible path to universal health insurance in the US and describes its potential benefits, limitations, and risks.
Graeme MacLaren, MBBS, MSc; Dale Fisher, MBBS; Daniel Brodie, MD
free access
JAMA. 2022;327(1):31-32. doi:10.1001/jama.2021.22580
This Viewpoint discusses the use of extracorporeal membrane oxygenation (ECMO) in treating patients with COVID-19 and how regional health care networks and governments should continue to monitor outcomes for patients with COVID-19 treated with ECMO to help manage ECMO resources for all critically ill patients.
Kristina E. Rudd, MD, MPH; Christina F. Mair, PhD, MPH; Derek C. Angus, MD, MPH
free access
JAMA. 2022;327(1):33-34. doi:10.1001/jama.2021.22583
This Viewpoint describes how syndemic theory, a way of analyzing harmful social conditions that contribute to chronic disease, could be applied to acute conditions of sepsis and COVID-19 that could guide the development of more precise strategies to clinical care, research, and health policies.